MENU
AGIO
AS OF
Nov 20, 04:59 PM (EDT)
Price
$24.55
Change
+$2.21 (+9.89%)
Capitalization
1.43B
84 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AGIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Agios Pharmaceuticals (AGIO) Ownership - Who owns Agios Pharmaceuticals?

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.43B
P/E Ratio
3.82
Total Cash
952.86M
Projected Growth
N/A
Total Debt
44.52M
Revenue
44.79M
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash/Share
16.34
Total Debt/Equity
N/A
Revenue/Share
0.77 USD as % of share price

Fundamentals

AGIO
Capitalization
1.43B
P/E Ratio
3.82
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash
953M
Total Cash/Share
16.34
Total Debt
44.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.77%
Revenue
44.8M
ROE
N/A
Book Value
1.28B
P/B Ratio
1.11
Cash Flow
N/A
Earnings
-6.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
74K
Current Ratio
13.82
Current Revenue Per Employee
26393.44
Dividends Per Share - Security
N/A
EBITDA
-470.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.96
Revenue To Assets
-25.26
Shares Held By Institutions
5.31B
Shares Outstanding - Current
58.3M
Total Liabilities
101M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-32.015
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AGIO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AGIO showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AGIO
A.I. Advisor
published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com